the drug also reduced ischemic changes in ecg , the incidence of myocardial infarction , histopathological changes and a decrease in serum high density lipoprotein cholesterol , and inhibited an increase in plasma thromboxane b2 and a decrease in plasma 6-keto-prostaglandin f1 alpha content in the animals with an experimental ischemic heart injury caused by the injection of thromboxane a2 into the coronary artery .
C0229671
serum
C0032105
plasma